Hematoxylin is the main component of Hematoxylon campechianum which has been utilized in the southern provinces of Korea as a folk remedy for diabetic complications. In the present study, to investigate the hypoglycemic mechanism of hematoxylin, the 2-deoxyglucose uptake and phospholipid metabolism were examined in sciatic nerves from three groups of rats : normal control, diabetic control, diabetic hematoxylin-treated group. Hematoxylin significantly reduced blood glucose levels in diabetic control rats. On a wet weight basis, the nerves from diabetic rats showed a 20% decrease in total phospholipid from that of controls and a relative decrease in phosphatidylinositide. Hematoxylin treatment increased the incorporation rate of 2-[3H] myo-inositol into total phosphoinositids in diabetic rat. The effectiveness were more potent in higher dose hematoxylin-treated rats than lower dose hematoxylin-treated rats. These results suggest that hematoxylin increases glucose transport and lipid metabolism by partially normalizing concerned with myo-inositol metabolism in diabetic rat. Therefore we propose that hematoxylin can be a promising candidate for diabetes medication. 
Introduction
Hematoxylin, which is a benzo(b)indeno(2,1-d) pyran derivative, has been used mainly as a staining material in cytologic research, food coloring agent and an antioxidant [1] . Many physiologic functions of hematoxylin have been reported by several scientists [2] [3] [4] [5] . It has also been reported that the decoction of Hematoxylon campechianum has been used for the treatment of diabetic complications in the folk medicine in the southern provinces of Korea. There have been some positive aspects of the application of the hematoxylin, such as in the improvement of diabetic retinopathy [6] [7] .
We have in vitro evidence that hematoxylin normalizes the glucose utilization in soleus muscle which is one of the active tissues in glucose metabolism. Based on these studies, we set out to elucidate the antidiabetic mechanism of hematoxylin using adipocytes as target cell for their high metabolic activity and hormonal response [8] . For the purpose of the study, we investigated the effects of hematoxylin on glucose transport and phospholipid metabolism in the sciatic nerves from streptozotocin -induced diabetic rats.
Materias and methods

Induction of Mild Diabetes Mellitus
Male Spraque-Dawely rats (160-180g) fasted overnight were injected with 40mg.kg -1 streptozotocin (STZ) through a tail vein [9] . STZ was dissolved in citrate buffer (pH 4.0), kept in ice bath, and administered within 10 minutes. These are important precautions in order to prevent the rapid inactivation of STZ at neutral pH and room temperature. After 7 days' stabilization of plasma glucose levels, blood samples were collected from retro plexus orbital in the nonfasting state between 09:00 and 10:00a.m. Plasma glucose was determined by the glucose-oxidase method, plasma insulin was determined by the double antibody radioimmunoassy. Animals with a similar degree of diabetic(blood glucose concentration 335mg% to 385mg%) were selected for this research. All rats had free access to fresh water and solid laboratory chow (Composition : crude protein 25%, crude fat 3.5%, Ca 20%, P 0.4%, crude cellulose 5.0%, and crude ash 8.0%) throughout the experiment.
Grouping and Treatment of Animals
Rats were divided into three groups: normal control, diabetic control and diabetic hematoxylin-treated group. 
Nerve incubations
Nerve incubations were prepared according to the procedure of Bell et a1 [10] . Immediately after dislocation, about 25mm segment of sciatic nerve was removed from each leg of the normal and diabetic rats by dissection from the sciatic notch to the popliteal fossa. Each nerve was performed in 0.5 ml of Krebs-Ringer-bicarbonate buffer, pH 7.4, which contained 5.5mM glucose and 0.5μ 
Measurement of Glucose Transport
Transport studies were performed using the oil flotation as technique described by Olefsky et al [11] . [12] . The assay was terminated at the end of 3mins by transferring 300μl aliquots from the assay mixture to a plastic microtube containing 100μl ) at the beginning of 1 hour preincubation and then glucose uptake was measured as described above.
Measurement and seperation of phospholipids.
Phospholipids were separated by one-dimensional high 
Statistical Analysis
To determine if the means of data were significantly different from each other or controls, the data were subjected to analysis followed by Duncan , s Multiple
Range test. In all case, p< 0.05 was used to determine significance.
Results
General Characteristics of Experimental Animals
Some characteristics of the experimental rats used in this study are summarized in Table 1 .
[ Table 1 ] General characteristics of experimental animals.
Check Time The STZ-induced diabetic rats consumed more food and water, but gained weight less rapidly than normal control rats. The plasma glucose levels were markedly increased but the plasma insulin levels were decreased in diabetic rats. From these results, the model of STZ-induced diabetic rat might be explained by reduction in plasma insulin level. The plasma glucose levels in hematoxylin-treated rats were significantly lower than those in diabetic control rats, while the difference of plasma insulin levels between the treated group and non-treated group was not found. Also, the body weights of diabetic hematoxylin-treated rats were somewhat higher than those of diabetic control rats, but the difference between the two groups was not statistically significant.
These results suggest that hematoxylin may affect plasma glucose levels without changing insulin secretion/level in diabetic status and it means hematoxylin could act in a different mode from the action of insulin in improving diabetic status. Thus to elucidate the
hypoglycemic mechanism of hematoxylin, we have assessed the rate of glucose uptake which is not only the first step but the rate limiting step in lipid metabolism using sciatic nerve.
in vivo Effects of Hematoxylin on 2-Deoxyglucose Uptake
First of all, to check the effectiveness of hematoxylin on glucose transport system in diabetic status, we examined the in vivo effects of hematoxylin using epididymal sciatic nerve from diabetic rats. Fig.1 and Diabetic status leaded to a decrease in both basal and insulin-stimulated rates of 2-deoxyglucose uptake, while hematoxylin increased only the insulin-stimulated rate of 2-deoxyglucose without affecting basal status.
in vitro Effects of Hematoxylin on 2-Deoxyglucose Uptake
Isolated sciatic nerve from diabetic rats were incubated with various concentrations of hematoxylin (10 NC (6) DC (9) DT1 (8) DT2 (8) DT3 (8) DT4 (8) 2-Deoxyglucose Uptake 3.4 Effects of Hematoxylin on Phosphatidyl -inositol metabolism. in normal treated rats (Fig.6-7) .
However, myo-inositol incorporation into phosphatidy -linositol-4,5-diphosphate was significantly increased but phospatidylphosphte decreased by the two different doses of hematoxylin administration in diabetic rat.
But there was no significant change of incorporation rate between high and low concentrations of hematoxylin.
Data presented in Fig.6 show that only incoperation into phophatidyl-4-phosphate was significantly decreased in nerves from diabetic rat.
These results suggest that the condiderable alteration in incorporation of these lipid precursors in diabetic nerves may be related to the impaired inositol uptake and these deficits were ameliorated by hematoxylin treatment and this effectiveness was more potent in diabetic state than in normal state.
NC (6) DC (9) DT1 (8) DT2 ( 
Discussion
This investigation has studied the effects of treatment of diabetic rats with hematoxylin on two common defects expressed with impaired glucose transport system and increased phospholipid metabolism in sciatic nerves [12] [13] [14] . Also in this study, sciatic nerves tissue was used as target organ for determining glucose transport, since it is active hormonally and metabolically in glucose metabolism.
In the study, the treatment of hematoxylin had a significant effect on the glucose level not insulin level in the diabetic rats. This phenomenon could be explained that hypoglycemic mechanism of hematoxylin was not at least due to normalization of insulin secreation in diabetic rat. There have been several reports concerning agents which improved diabetic status not affecting insulin level [15] [16] . We considered that hematoxylin might have a similar action mode like these reagents. From the observations in in vivo and in vitro studies, it was more cleared that hematoxylin normalized in part glucose level by increasing glucose transport and this increased uptake by hematoxylin was resulted from change of insulin sensitivity in diabetic status. The normalization degree by hematoxylin was higher in the presence of insulin than that of in the absence of insulin and its pattern was dose dependent manner ( Fig. 2 and Fig. 4 ). But it is noticeable that both basal and insulin-stimulated rate of the 2-deoxyglucose uptake was reduced at the highest concentration of hematoxylin (10 -3 M). This could be explained as toxic effects on sciatic nerves due to the unusually high concentration of hematoxylin.
But in the sciatic nerves from hematoxylin-treated rats, even though glucose level taken into account at diabetic status, the decrease rate of glucose uptake was much lower than that of untreated-rats In conclusion, we have found that hematoxylin decreased blood glucose level by increase utilization of glucose metabolism in diabetic status regardless of insulin level and its mechanism could be explained by an increase Vmax of 2-deoxyglucose in sciatic nerves, indicating that it could be used as an antidiabetic therapeutic agent. Despite this finding, to get reach the accurate hypoglycemic mechanism of hematoxylin, many problems including insulin signaling system, glucose metabolism pathway such as glucose oxidation and lipogenesis should be further investigated.
Especially peripheral nerves sodium-potassium ATPase is fundamental to both energy and substrate, metabolism, 
